Biomarkers of disease in a case of familial lower motor neuron ALS

Abstract ALS is a fatal disease with variable clinical course. There is no single reliable marker of disease progression. Sufficient records were available to study the case history of four family members with the uncommon G93V SOD1 mutation. Distal lower motor neuron (LMN) involvement occurred in all family members with onset from 30 to 51 years of age, with progression over more than six years. Between 2002 and 2009, we used electrophysiology as a biomarker to study disease progression in one patient, assessing the number of motor units in three nerves from different limbs. The loss of motor units showed an exponential decline with different half-lives in different nerves. Diffusion tractography was compared with a control to assess upper motor neuron (UMN) involvement and showed asymmetric evidence of abnormalities of the corticospinal tracts, providing evidence of central involvement despite the absence of UMN signs.

[1]  D. Borchelt,et al.  Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.

[2]  Matthew C Kiernan,et al.  Biomarkers in amyotrophic lateral sclerosis , 2009, The Lancet Neurology.

[3]  A. Chiò,et al.  The rare G93D mutation causes a slowly progressing lower motor neuron disease , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[4]  Joleen H Blok,et al.  The electrophysiological muscle scan , 2007, Muscle & nerve.

[5]  Anthony N Pettitt,et al.  Bayesian statistical MUNE method , 2007, Muscle & nerve.

[6]  Alan Connelly,et al.  Robust determination of the fibre orientation distribution in diffusion MRI: Non-negativity constrained super-resolved spherical deconvolution , 2007, NeuroImage.

[7]  M. Kiernan,et al.  Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  Anthony N Pettitt,et al.  Motor Unit Number Estimation—A Bayesian Approach , 2006, Biometrics.

[9]  W. Robberecht,et al.  The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. , 2006, Archives of neurology.

[10]  G. Forster,et al.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS , 2003, Neurology.

[11]  C J Lumsden,et al.  Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. , 2001, Human molecular genetics.

[12]  H. Horvitz,et al.  Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis , 1996, Neuromuscular Disorders.

[13]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[14]  Mb Alan J. McComas Dr.,et al.  The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. , 1991 .

[15]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.